Skip to content
10-Q

Quarterly Report

TELADOC HEALTH, INC. TDOC

0001477449-26-000028

← back to feed
Filed
Apr 30, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · Apr 23, 2026 180.51M sh
Shares Diluted Q1 2026 · Mar 31, 2026 179.12M sh
Shares Diluted Q1 2026 · Mar 31, 2025 174.15M sh
Capex Q1 2026 · Mar 31, 2026 $1.66M
Capex Q1 2026 · Mar 31, 2025 $2.73M
Operating Cash Flow Q1 2026 · Mar 31, 2026 $9.52M
Operating Cash Flow Q1 2026 · Mar 31, 2025 $15.92M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $750.74M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $781.08M
Stockholders Equity Q1 2026 · Mar 31, 2026 $1.34B
Stockholders Equity Q1 2026 · Dec 31, 2025 $1.39B
Stockholders Equity Q1 2026 · Mar 31, 2025 $1.43B
Stockholders Equity Q1 2026 · Dec 31, 2024 $1.49B
Current Liabilities Q1 2026 · Mar 31, 2026 $404.87M
Current Liabilities Q1 2026 · Dec 31, 2025 $404.74M
Total Liabilities Q1 2026 · Mar 31, 2026 $1.47B
Total Liabilities Q1 2026 · Dec 31, 2025 $1.47B
Current Assets Q1 2026 · Mar 31, 2026 $1.13B
Current Assets Q1 2026 · Dec 31, 2025 $1.12B
Total Assets Q1 2026 · Mar 31, 2026 $2.81B
Total Assets Q1 2026 · Dec 31, 2025 $2.86B
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.36
Eps Diluted Q1 2026 · Mar 31, 2025 −$0.53
Eps Basic Q1 2026 · Mar 31, 2026 −$0.36
Eps Basic Q1 2026 · Mar 31, 2025 −$0.53
Sga Expense Q1 2026 · Mar 31, 2026 $102.09M
Sga Expense Q1 2026 · Mar 31, 2025 $112.77M
Rd Expense Q1 2026 · Mar 31, 2026 $67.87M
Rd Expense Q1 2026 · Mar 31, 2025 $69.96M
Net Income Q1 2026 · Mar 31, 2026 −$63.84M
Net Income Q1 2026 · Mar 31, 2025 −$93.01M
Operating Income Q1 2026 · Mar 31, 2026 −$61.77M
Operating Income Q1 2026 · Mar 31, 2025 −$120.61M
Revenue Q1 2026 · Mar 31, 2026 $613.85M
Revenue Q1 2026 · Mar 31, 2025 $629.37M